The Genomics Revolution: Will This Mean a Resurgence of Customized Prescriptions?

Abstract

Get full access to this article

View all access options for this article.

References

Miners

Birkett

Cytochrome P4502C9: An enzyme of major importance in human drug metabolism. Br J Pharmacol. 1998;45:525–538.

Aithal

Day

Kesteven

PJL

Daly

Association of polymorphisms in the cytochrome P450 CYP 2C9 with warfarin dose requirement and risk of bleeding complications. The Lancet. 1999;353:717–719.

Evans

Relling

Pharmacogenomics: Translating functional genomics into rational therapeutics. Science. 1999;286:487–491.

Meyer

Pharmacogenetics and adverse drugs reactions. The Lancet. 2000;356:1667–1671.

Wolf

Smith

Pharmacogenetics. Science, medicine and the future. Br Med J. 2000;320:987–990.

Phillips

Veenstra

Oren

Lee

Sadee

Potential role of pharmacogenomics in reducing adverse drug reactions. JAMA. 2001;286:2270–2279.